Stockscreener 앱 받기
36.51
2.67%
-1.00
전일 마감가:
$37.51
열려 있는:
$36.94
하루 거래량:
3.45M
Relative Volume:
1.46
시가총액:
$5.55B
수익:
$3.44B
순이익/손실:
$75.20M
주가수익비율:
69.69
EPS:
0.5239
순현금흐름:
$49.30M
1주 성능:
-12.93%
1개월 성능:
-28.24%
6개월 성능:
+5.70%
1년 성능:
-28.62%
1일 변동 폭
$36.11
$37.79
1주일 범위
$35.62
$42.58
52주 변동 폭
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
명칭
Bruker Corp
전화
978663-3660
주소
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
36.51 | 5.70B | 3.44B | 75.20M | 49.30M | 0.5239 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-10 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | 개시 | Goldman | Sell |
| 2025-11-20 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-19 | 개시 | Guggenheim | Buy |
| 2024-12-10 | 개시 | UBS | Neutral |
| 2024-12-05 | 업그레이드 | Goldman | Sell → Neutral |
| 2024-10-15 | 개시 | Barclays | Overweight |
| 2024-09-30 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2022-10-21 | 개시 | UBS | Buy |
| 2022-08-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2021-02-05 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | 개시 | Goldman | Sell |
| 2020-11-16 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | 다운그레이드 | Cleveland Research | Buy → Neutral |
| 2020-04-02 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | 다운그레이드 | Needham | Strong Buy → Hold |
| 2020-03-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2019-06-24 | 재확인 | Needham | Strong Buy |
| 2019-06-21 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-30 | 개시 | Wolfe Research | Peer Perform |
| 2019-05-06 | 재확인 | Needham | Strong Buy |
| 2019-05-03 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | 업그레이드 | UBS | Sell → Neutral |
| 2019-04-12 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-02-12 | 재확인 | BTIG Research | Buy |
| 2019-01-03 | 개시 | Needham | Strong Buy |
모두보기
Bruker Corp 주식(BRKR)의 최신 뉴스
A Look At Bruker (BRKR) Valuation After Mixed Earnings And Soft 2026 Growth Outlook - Yahoo Finance
Forecasting The Future: 15 Analyst Projections For Bruker - Benzinga
Bruker (BRKR) Price Target Lowered by Citigroup, Rating Maintained | BRKR Stock News - GuruFocus
These Analysts Cut Their Forecasts On Bruker Following Q4 Results - Benzinga
Bruker (BRKR) Target Price Adjustment: Barclays Lowers Price Tar - GuruFocus
Bruker Corporation (NASDAQ:BRKR) Q4 2025 Earnings Call Transcript - Insider Monkey
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $40 to $53 - 富途牛牛
Bruker Shares Tumble on Q4 Earnings Miss and Weaker Margins Despite 2026 Growth Outlook - AlphaStreet News
Jefferies Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $50 - 富途牛牛
Bruker Corp (BRKR) Q4 2025 Earnings Call Highlights: Navigating Challenges and Setting the ... - Yahoo Finance
Bruker (NASDAQ:BRKR) Announces Earnings Results - MarketBeat
Why Bruker (BRKR) Stock Is Trading Lower Today - Finviz
Bruker Q4 2025 slides reveal organic decline, stock drops 14% despite FY 2026 optimism - Investing.com
Bruker (BRKR) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Earnings call transcript: Bruker Q4 2025 earnings miss, stock drops 14% - Investing.com
Bruker: Q4 Financial Results Overview - Bitget
Bruker (BRKR) Q4 Earnings Miss Estimates - Yahoo Finance
Bruker: Q4 Earnings Snapshot - kare11.com
Bruker’s (NASDAQ:BRKR) Q4 CY2025 Sales Beat Estimates - Yahoo Finance
Bruker earnings missed by $0.06, revenue topped estimates - Investing.com
Bruker Corporation Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
Bruker Earnings Review: Q4 Summary - Benzinga
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results - Yahoo Finance
Bruker earnings up next: Can momentum continue after Q3 beat? - Investing.com
A Glimpse of Bruker's Earnings Potential - Benzinga
Candriam S.C.A. Cuts Stock Position in Bruker Corporation $BRKR - MarketBeat
Bruker Corporation Announces the Launch of iNTApharma - marketscreener.com
Bruker (BRKR) Launches iNTApharma for Advanced Bioparticle Analy - GuruFocus
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC - ChartMill
Bruker Announces Quarterly Preferred Stock Dividend - 富途牛牛
Old West Investment Management LLC Buys 338,618 Shares of Bruker Corporation $BRKR - MarketBeat
Shareholders in Bruker (NASDAQ:BRKR) have lost 43%, as stock drops 7.2% this past week - Yahoo Finance
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for - Finviz
Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast - marketscreener.com
Bruker (BRKR) to Release Quarterly Earnings on Thursday - MarketBeat
New York State Common Retirement Fund Has $12.05 Million Stake in Bruker Corporation $BRKR - MarketBeat
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $55 - 富途牛牛
Guggenheim Raises Price Target for Bruker Corporation (BRKR) - Finviz
Will Bruker Corporation outperform its industry peersGDP Growth & Proven Capital Preservation Tips - Mfd.ru
Levels Update: Will Bruker Corporation stock recover after earningsJuly 2025 Rallies & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Eclipse Bioinnovations, Inc. acquired Terrain Biosciences, Inc. from Magnetic Ventures and Bruker Corporation. - marketscreener.com
Bruker Corp (BRKR) Shares Down 2.98% on Jan 26 - GuruFocus
Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $58 - 富途牛牛
Stocks To Watch: Bruker Sees Relative Strength Rating Rise To 82 - Investor's Business Daily
Bruker Corporation (BRKR): A Bull Case Theory - Finviz
TOFWERK joins Bruker: From partnership to full ownership - MSN
Revenues Working Against Bruker Corporation's (NASDAQ:BRKR) Share Price - 富途资讯
SG Americas Securities LLC Has $1.37 Million Stake in Bruker Corporation $BRKR - MarketBeat
Assessing Bruker (BRKR) Valuation After Recent Share Price Rebound And Conflicting Fair Value Signals - Yahoo Finance
Bruker (NASDAQ:BRKR) VP Sells $98,400.00 in Stock - MarketBeat
Citigroup Boosts Bruker (BRKR) Price Target, Maintains Neutral R - GuruFocus
Bruker Corp (BRKR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Bruker Corp 주식 (BRKR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Jan 15 '26 |
Option Exercise |
22.19 |
2,000 |
44,380 |
130,443 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Jan 15 '26 |
Sale |
49.20 |
2,000 |
98,400 |
128,443 |
1.33%
0.51%
자본화:
|
볼륨(24시간):